Challenges in the pathology of non-muscle-invasive bladder cancer: A dialogue between the urologic surgeon and the pathologist

Urology

Volumn 81, Issue 6, 2013, Pages 1123-1130

  Hansel, Donna E ^a,b   Miller, Jeremy S ^b   Cookson, Michael S ^b   Chang, Sam S ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL SPECIALIST; NON MUSCLE INVASIVE BLADDER CANCER; PATHOLOGIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPECIALIZATION; STANDARDIZATION; SURGEON; TISSUE SECTION; TOTAL QUALITY MANAGEMENT; UROLOGIST; WORLD HEALTH ORGANIZATION;

CARCINOMA; HUMANS; INTERDISCIPLINARY COMMUNICATION; NEOPLASM INVASIVENESS; PATHOLOGY; PATIENT CARE TEAM; SPECIMEN HANDLING; URINARY BLADDER NEOPLASMS; UROLOGY;

EID: 84878550425     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.01.027     Document Type: Article

References (46)

1. American Cancer Society. Cancer Facts and Figures. Available at: http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/ cancer-facts-figures-2012. Accessed March 2, 2012.
2. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
3. National Cancer Institute. General information about bladder cancer. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/bladder/ HealthProfessional/. Accessed March 2, 2012.
4. A. Böhle, D. Jocham, and P.R. Bock Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity J Urol 169 2003 90 95
5. V. Pansadoro, P. Emiliozzi, and F. de Paula Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience Urology 59 2002 227 231
6. S.P. Lerner, C.M. Tangen, and H. Sucharew Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer Urol Oncol 27 2009 155 159
7. C.R. Lockyer, J.E. Sedgwick, and D.A. Gillatt Beware the BCG failures: a review of one institution's results Eur Urol 42 2002 542 546
8. R.J. Sylvester, A.P. van der Meijden, and J.A. Witjes Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials J Urol 174 2005 86 91 [discussion: 91-92]
9. M. Babjuk, W. Oosterlinck, and R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997 1008
10. K. Chamie, C.S. Saigal, and J. Lai Compliance with guidelines for patients with bladder cancer: variation in the delivery of care Cancer 117 2011 5392 5401
11. M.F. Botteman, C.L. Pashos, and A. Redaelli The health economics of bladder cancer: a comprehensive review of the published literature Pharmacoeconomics 21 2003 1315 1330
12. D.E. Hansel, M.B. Amin, and E. Comperat A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens Eur Urol 63 2013 321 332
13. M.B. Amin, J.K. McKenney, and G.P. Paner ICUD-EAU International Consultation on Bladder Cancer 2012: pathology Eur Urol 63 2013 16 35
14. National Institute for Health and Clinical Excellence. Improving outcomes in urological cancers. The manual. Guidance on cancer services. Available at: http://www.nice.org.uk. Accessed March 5, 2012.
15. S.M. Powsner, J. Costa, and R.J. Homer Clinicians are from Mars and pathologists are from Venus Arch Pathol Lab Med 124 2000 1040 1046
16. A. Chandra, D. Griffiths, and L.J. McWilliam Best practice: gross examination and sampling of surgical specimens from the urinary bladder J Clin Pathol 63 2010 475 479
17. L. Cheng, R. Montironi, and D.D. Davidson Staging and reporting of urothelial carcinoma of the urinary bladder Mod Pathol 22 Suppl 2 2009 S70 S95
18. A. Lopez-Beltran, F. Algaba, and D.M. Berney Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP) Histopathology 58 2011 579 585
19. T.R. Coblentz, S.E. Mills, and D. Theodorescu Impact of second opinion pathology in the definitive management of patients with bladder carcinoma Cancer 91 2001 1284 1290
20. W.M. Murphy, I. Rivera-Ramirez, and L.G. Luciani Second opinion of anatomical pathology: a complex issue not easily reduced to matters of right and wrong J Urol 165 6 Pt 1 2001 1957 1959
21. K.S. Han, J.Y. Joung, and K.S. Cho Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: the referral cancer center experience and review of the literature J Endourol 22 2008 2699 2704
22. M.C. Lee, H.S. Levin, and J.S. Jones The role of pathology review of transurethral bladder tumor resection specimens in the modern era J Urol 183 2010 921 927
23. L. Egevad, F. Algaba, and D.M. Berney The European Network of Uropathology: a novel mechanism for communication between pathologists Anal Quant Cytol Histol 31 2009 90 95
24. J.N. Eble, G. Sauter, and J.I. Epstein Pathology and genetics of tumours of the urinary system and male genital organs P. Kleihues, L.H. Sobin, World Health Organization Classification of Tumours 2004 WHO Publications Lyon, France
25. F.K. Mostofi, L.H. Sobin, and H. Torloni Histologic typing of urinary bladder tumors 1973 World Health Organization Geneva, Switzerland
26. F.K. Mostofi, C.J. Davis, and I.A. Sesterhenn World Health Organization international histological classification of tumours. Histological typing of urinary bladder tumours 2nd ed. 1999 Springer Verlag Berlin, Germany
27. A. Lopez-Beltran, P. Bassi, and M. Pavone-Macaluso Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis Eur Urol 45 2004 257 266
28. M. Matsushima, E. Kikuchi, and M. Hasegawa Clinical impact of bladder biopsies with TUR-BT according to cytology results in patients with bladder cancer: a case control study BMC Urol 10 2010 12
29. M. Brausi, J.A. Witjes, and D. Lamm A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group J Urol 186 2011 2158 2167
30. TM): bladder cancer, version 2.2012 2012 National Comprehensive Cancer Network Fort Washington, PA
31. College of American Pathologists. Protocol for the examination of specimens from patients with carcinoma of the urinary bladder. Available at: http://www.cap.org/apps/docs/committees/cancer/cancer-protocols/2011/ RenalPelvUreter-11protocol.pdf. Accessed January 18, 2012.
32. M. Buscarini, and M. Conlin Update on flexible ureteroscopy Urol Int 80 2008 1 7
33. W.C. Bell, E.S. Young, and P.E. Billings The efficient operation of the surgical pathology gross room Biotech Histochem 83 2008 71 82
34. Organisation for Economic Co-operation and Development. OECD Best Practice Guidelines for Biological Resource Centres. Available at: http://www.oecd.org/dataoecd/7/13/38777417.pdf. Accessed March 6, 2012.
35. International Society for Biological and Environmental Repositories. 2008 Best practices for repositories: collection, storage, retrieval and distribution of biological materials for research. Campbell LD, Skubitz APN, Somiari SB, eds. Mary Ann Liebert, Inc. Available at: http://www.isber.org/bp/ BestPractices2008.pdf. Accessed March 6, 2012.
36. NCI best practices for biospecimen resources. Office of Biorepositories and Biospecimen Research, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Available at: http://biospecimens.cancer.gov/bestpractices/2011-NCIBestPractices.pdf. Accessed January 24, 2012.
37. College of American Pathologists: CAP accreditation for biorepositories. The first standardization for biospecimen management. Available at: http://www.cap.org/apps/docs/laboratory-accreditation/lap-info/ bio-brochure-042011.pdf. Accessed January 18, 2012.
38. R.E. Nakhleh Core components of a comprehensive quality assurance program in anatomic pathology Adv Anat Pathol 16 2009 418 423
39. N. Nese, R. Gupta, and M.H. Bui Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis J Natl Compr Canc Netw 7 2009 48 57
40. American Urological Association Education and Research. The Management of Bladder Cancer: Diagnosis and Treatment Recommendations. Available at: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/ main-reports/bladcan07/chapter1.pdf. Accessed February 8, 2012.
41. M.B. Amin Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications Mod Pathol 22 Suppl 2 2009 S96 S118
42. C. Daniel, F. Macary, and M.G. Rojo Recent advances in standards for Collaborative Digital Anatomic Pathology Diagn Pathol 6 Suppl 1 2011 S17
43. L. Hassell, W. Aldinger, and C. Moody Electronic capture and communication of synoptic cancer data elements from pathology reports: results of the Reporting Pathology Protocols 2 (RPP2) project J Registry Manag 36 2009 117 124 quiz 163-165
44. M. Singh, and T.R. Pal Voice recognition technology implementation in surgical pathology: advantages and limitations Arch Pathol Lab Med 135 2011 1476 1481
45. H.P. Kang, S.J. Sirintrapun, and R.J. Nestler Experience with voice recognition in surgical pathology at a large academic multi-institutional center Am J Clin Pathol 133 2010 156 159
46. American Joint Committee on Cancer AJCC Cancer Staging Manual 7th ed. 2010 Springer Chicago, IL 1-650